Wealthcare Capital Management’s Xylem XYL Stock Holding History

Wealthcare Capital Management’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-28	Closed	-$2K	–	663
2019 Q4	$2K	Buy	+28	New	+$2.18K	﹤0.01%	593

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wealthcare Capital Management's XYL Position: Q1 2020 in Review

Wealthcare Capital Management sold out of Xylem (XYL) in Q1 2020, closing a stake of 28 shares — an estimated $2K sold.

Wealthcare Capital Management first reported a position in XYL in Q4 2019 and held it in 1 quarter. The position peaked at $2K in Q4 2019. 671 funds tracked by Wall St. Rank hold XYL as of Q1 2020.

Wealthcare Capital Management reported no remaining Xylem position as of Q1 2020 after selling out during the quarter.
Wealthcare Capital Management sold 28 Xylem shares in Q1 2020, an estimated $2K.
Wealthcare Capital Management first reported a position in Xylem in Q4 2019 and held it in 1 quarter.
Wealthcare Capital Management's Xylem position peaked at $2K in Q4 2019.
671 funds tracked by Wall St. Rank held Xylem as of Q1 2020.

Based on Wealthcare Capital Management's 13F filing for Q1 2020, filed 29 Apr 2020.